Compare Intuit Inc. (INTU) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuit Inc. vs Zoetis Inc — how do they compare? Intuit Inc. trades at $279.49 (market cap $80.37B), while Zoetis Inc trades at $76.1 (market cap $31.95B). The key difference: Intuit Inc. is far larger — about 2.5× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| INTU | ZTS | |
|---|---|---|
Market Cap | $80.37B | $31.95B |
Sector | Technology | Health |
52-Week High | $807.39 | $156.76 |
52-Week Low | $255.07 | $71.91 |
Enterprise Value | $78.83B | $39.24B |
Dividend Yield | 1.63% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuit (INTU) trades at $293.82, up 0.94% on the day, with a bullish technical signal and strong fundamental performance. Recent earnings beats, including Q1 2026 EPS of $12.8 versus $12.57 expected, highlight robust profitability. The stock faces headwinds from legal investigations into pricing disclosures, contributing to a 20% drop from 2025 highs, but maintains a consensus analyst price target of $423.11 with 71% buy ratings.
The outlook is mixed: strong revenue growth and AI-driven product expansion support upside, but legal risks and competitive pressures pose significant threats. Investors should weigh the company's solid financials against ongoing litigation and market sentiment shifts for balanced risk-reward assessment.
Zoetis (ZTS) trades at $76.05, down 0.67% on the day, with a neutral technical signal and bearish moving averages. The company maintains strong fundamentals with a 28.03% net income margin and 67.75% ROE, though Q1 2026 earnings missed expectations. Recent news highlights multiple securities class action lawsuits filed against the company, creating near-term uncertainty despite the launch of new product Lenivia in Canada and EU markets.
The stock presents a mixed outlook with attractive valuation metrics (P/E 12.55) and analyst consensus price target of $101.43 suggesting 33% upside potential. However, legal challenges and the recent earnings miss pose significant near-term risks. Institutional sentiment remains divided with 47% buy ratings versus 53% hold ratings, indicating cautious optimism amid legal headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuit Inc.
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
